SCHEMBL962872

SCHEMBL962872

CCCCCCCCCCC(O)CNCC(O)CCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.52
FFAR1 O14842 2/20 0.50
FFAR4 Q5NUL3 1/20 0.50
SPHK1 Q9NYA1 1/20 0.45
FAAH O00519 2/20 0.44
LMNA P02545 1/20 0.44
PSMD14 O00487 2/20 0.44
PLA2G1B P04054 2/20 0.44
MMP2 P08253 2/20 0.44
ATG4B Q9Y4P1 2/20 0.44
HSP90AA1 P07900 1/20 0.44
RAD52 P43351 1/20 0.44
NFKB1 P19838 1/20 0.44
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL967032 1.00 GPR84 (0.52) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL966292 1.00 GPR84 (0.52) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL965314 1.00 GPR84 (0.52) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL964096 1.00 GPR84 (0.52) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL963776 1.00 GPR84 (0.52) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL27462274 0.94 GPR84 (0.47) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL11761031 0.92 GPR84 (0.46) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL11410403 0.92 LMNA (0.48) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL29032096 0.92 GPR84 (0.46) GPR84FFAR1FFAR4SPHK1FAAH
SCHEMBL11764478 0.92 GPR84 (0.46) GPR84FFAR1FFAR4SPHK1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4522984-A WITH E-CAPROLACTONE DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1985-06-11 US claimed
EP-4400107-A1 IONIZABLE LIPOSOME, PREPARATION THEREOF, AND APPLICATION THEREOF IN GENE DELIVERY Maxirna (Zhejiang) Technology Co., Ltd. (CN) 2024-07-17 EP disclosed
WO-2024119074-A1 STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING GENERATION BIO CO. (US) 2024-06-06 WO disclosed
US-20210301217-A1 LUBRICATING COMPOSITION AND METHOD OF FORMATION RELATING THERETO IDEMITSU KOSAN Ltd. (JP) 2021-09-30 US disclosed
US-9512073-B2 Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-12-06 US disclosed
EP-2280057-B2 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE IDEMITSU KOSAN CO (JP) 2016-11-23 EP disclosed
US-9321981-B2 Lubricating oil composition for internal combustion engine IDEMITSU KOSAN CO., LTD. (JP) 2016-04-26 US disclosed
EP-2280057-B1 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE IDEMITSU KOSAN CO (JP) 2013-09-11 EP disclosed
US-20130158021-A1 AMINO ACID-, PEPTIDE-AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-06-20 US disclosed
WO-2013063468-A1 AMINO ACID DERIVATES FUNCTIONALIZED ON THE N- TERMINAL CAPABLE OF FORMING DRUG INCAPSULATING MICROSPHERES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-05-02 WO disclosed
EP-2280057-A1 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE Idemitsu Kosan Co., Ltd. (JP) 2011-02-02 EP disclosed
US-20110021393-A1 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE IDEMITSU KOSAN CO., LTD. (JP) 2011-01-27 US disclosed
US-7820599-B2 Lubricating oil composition IDEMITSU KOSAN CO., LTD. (JP) 2010-10-26 US disclosed
US-20090082233-A1 LUBRICATING OIL COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2009-03-26 US disclosed
US-6632968-B2 Reacting epoxide (epoxydecane) with ammonia and hydrogen in presence of catalyst BASF AKTIENGESELLSCHAFT (DE) 2003-10-14 US disclosed
US-4522984-A WITH E-CAPROLACTONE DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1985-06-11 US disclosed
US-4521570-A Modified epoxy resin and composition DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1985-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158021-A1 AMINO ACID-, PEPTIDE-AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF APLNR, NPPA, ARGLU1 GPR84 225/4885FFAR1 129/4885FFAR4 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.